Ohngren's line

From WikiMD's WELLNESSPEDIA

Ohngren's line is a theoretical line used in the staging of pancreatic cancer. It is drawn from the medial canthus of the eye to the angle of the mandible. Tumors anterior to this line are considered resectable, while those posterior to the line are considered unresectable.

Definition[edit]

Ohngren's line is an imaginary line drawn from the medial canthus (the inner corner of the eye) to the angle of the mandible (the lower jawbone). This line is used to determine the resectability of pancreatic cancer tumors. Tumors that are located anterior (in front of) to this line are generally considered resectable, meaning they can be surgically removed. Tumors that are located posterior (behind) to this line are generally considered unresectable, meaning they cannot be surgically removed.

Clinical Significance[edit]

The clinical significance of Ohngren's line lies in its use as a tool for staging pancreatic cancer. The location of a tumor in relation to this line can provide valuable information about the extent of the disease and the potential for surgical intervention. It is important to note, however, that the use of Ohngren's line is just one aspect of a comprehensive cancer staging process. Other factors, such as the size of the tumor, the presence of metastasis, and the patient's overall health, also play a crucial role in determining the appropriate treatment approach.

Limitations[edit]

While Ohngren's line can provide useful information about the resectability of pancreatic cancer tumors, it is not without limitations. For example, it does not take into account the size of the tumor or the presence of metastasis, both of which can significantly impact the feasibility of surgical intervention. Furthermore, the line is based on anatomical landmarks that can vary between individuals, potentially leading to inaccuracies in its application.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.